GIP
AMRI

Granite Investment Partners’s Albany Molecular Research Inc AMRI Stock Holding History

Granite Investment Partners’s Portfolio AMRI Stock Details AMRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-376,953
Closed -$7.48M – 323
2015
Q4 		$7.48M Buy
376,953
+4,586
+1% +$87.2K 0.68% 48
2015
Q3 		$6.49M Buy
372,367
+68,580
+23% +$1.4M 0.62% 58
2015
Q2 		$6.14M Buy
303,787
+70,371
+30% +$1.36M 0.57% 68
2015
Q1 		$4.11M Buy
+233,416
New +$3.98M 0.35% 109

Other funds holding AMRI

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
OWP
Obermeyer Wealth Partners Aspen, Colorado $2.17B AUM 19.33% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VNIM
Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
ACM
American Capital Management New York $1.86B AUM 20.23% 1-Year Est. Return
PIP
Permian Investment Partners Dallas, Texas $905M AUM 13.43% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Granite Investment Partners's AMRI Position: Q1 2016 in Review

Granite Investment Partners sold out of Albany Molecular Research Inc (AMRI) in Q1 2016, closing a stake of 376,953 shares — an estimated $7.48M sold.

Granite Investment Partners first reported a position in AMRI in Q1 2015 and held it in 4 quarters. The position peaked at $7.48M in Q4 2015. 141 funds tracked by Wall St. Rank hold AMRI as of Q1 2016.

  • Granite Investment Partners reported no remaining Albany Molecular Research Inc position as of Q1 2016 after selling out during the quarter.
  • Granite Investment Partners sold 376,953 Albany Molecular Research Inc shares in Q1 2016, an estimated $7.48M.
  • Granite Investment Partners first reported a position in Albany Molecular Research Inc in Q1 2015 and held it in 4 quarters.
  • Granite Investment Partners's Albany Molecular Research Inc position peaked at $7.48M in Q4 2015.
  • 141 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q1 2016.

Based on Granite Investment Partners's 13F filing for Q1 2016, filed 27 Apr 2016.